Key points for anticoagulants
The NPS Medicinewise educational program Oral anticoagulants — achieving good anticoagulant practice reviews current guidance for health professionals on the role of warfarin and the newer oral anticoagulants in preventing stroke and venous thromboembolism.
- Assess stroke risk to determine treatment, then identify and manage modifiable bleeding risk factors.
- Discuss benefits, harms and lifestyle factors with the patient when selecting and reviewing oral anticoagulant treatment.
- Use a structured approach to optimising warfarin management.
- All people taking oral anticoagulants need individualised clinical monitoring.
- The NPS Medicinewise educational program Oral anticoagulants — achieving good anticoagulant practice focusses on optimal use of warfarin and the newer oral anticoagulants dabigatran, rivaroxaban and apixaban (see program Key messages).
- The February 2013 NPS Medicinewise News discusses good anticoagulant practice, particularly use of oral anticoagulants in stroke prevention for people with non-valvular AF.
- Recent NPS RADAR articles have discussed the evidence behind use of: